Correlation of Rv0191 and Rv3008 Efflux Pump Gene Overexpression with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis

Overview

Revise to specify the findings regarding the correlation between gene overexpression and PZA resistance.

Background

Tuberculosis (TB) remains a leading cause of global mortality, with significant drug resistance complicating treatment efforts. The emergence of multidrug-resistant strains of Mycobacterium tuberculosis necessitates a deeper understanding of resistance mechanisms, particularly the role of efflux pumps. This study focuses on the Rv0191 and Rv3008 efflux pumps, which have been implicated in PZA resistance, to enhance treatment strategies.

Data Highlights

No numerical data provided in the source material.

Key Findings

• Overexpression of Rv0191 and Rv3008 is significantly associated with PZA resistance in multidrug-resistant M. tuberculosis.
• Approximately 18% of PZA-resistant isolates lack pncA mutations, indicating alternative resistance mechanisms.
• Efflux pumps Rv0191 and Rv3008 may contribute to reduced drug efficacy by actively transporting PZA out of the bacterial cell.
• Clinical isolates from Khuzestan and Khorasan provinces were analyzed, revealing regional differences in TB incidence and resistance patterns.
• Increased transcription levels of Rv0191 and Rv3008 correlate with weak but statistically significant resistance to PZA.

Clinical Implications

Understanding the role of Rv0191 and Rv3008 in PZA resistance can inform treatment decisions for multidrug-resistant TB. Clinicians should consider the potential for efflux pump overexpression when evaluating resistance patterns and tailoring therapy.

Conclusion

The study highlights the importance of efflux pump gene expression in the development of PZA resistance in multidrug-resistant M. tuberculosis. Further research is needed to explore these mechanisms and their implications for treatment.

References

1. Association between overexpression of efflux pumps genes Rv0191 and Rv3008 and pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis: a multi-center study - PMC
2. The Journal of Infectious Diseases — Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates
3. Open Forum Infectious Diseases — Challenges Associated with the MTB/RIF Assay: A Review of Four Clinical Cases
4. The Journal of Infectious Diseases — Genomic Analysis of Global Mycobacterium abscessus Isolates Reveals Ongoing Evolution of Drug Resistance–Associated Genes
5. Summary of recommendations - WHO consolidated guidelines on tuberculosis - NCBI Bookshelf
6. M. tuberculosis PZA test — BCCDC
7. Open Forum Infectious Diseases — Extensive Endemic Transmission of Multidrug-Resistant Mycobacterium tuberculosis in Bhutan: A Retrospective Genomic-Epidemiological Study
8. Summary of recommendations - WHO consolidated guidelines on tuberculosis - NCBI Bookshelf
9. DATE: May 26, 2025 RE: M. tuberculosis PZA test
10. Association between overexpression of efflux pumps genes Rv0191 and Rv3008 and pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis: a multi-center study - PMC